OW 2025 4 - 7 November 2025

STEP UP: Efficacy of Semaglutide in Obesity Treatment Targets and Cardiovascular Risk Thresholds

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Obesity
Congress oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)